The risk or severity of adverse effects can be increased when dantrolene is combined with citalopram.


The risk or severity of adverse effects can be increased when Toloxatone is combined with formoterol.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with memantine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Sacubitril is combined with tolmetin.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Pipamperone.


The risk or severity of adverse effects can be increased when epirizole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Vilanterol is combined with leflunomide.


The risk or severity of adverse effects can be increased when hydroxyamphetamine is combined with selegiline.


The risk or severity of adverse effects can be increased when sulconazole is combined with Pregabalin.


The risk or severity of adverse effects can be increased when halcinonide is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Difenoxin.


The risk or severity of adverse effects can be increased when epirizole is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when ethopropazine is combined with oxyphenonium.


The risk or severity of adverse effects can be increased when propantheline is combined with oxyphenonium.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when amitriptyline is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with amisulpride.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with memantine.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Flibanserin.


The risk or severity of adverse effects can be increased when sulconazole is combined with xylometazoline.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with nifedipine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with zonisamide.


The risk or severity of adverse effects can be increased when nalbuphine is combined with tiagabine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with cocaine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with ondansetron.


The risk or severity of adverse effects can be increased when nalbuphine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when ipratropium is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when dyclonine is combined with topiramate.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with loratadine.


The risk or severity of adverse effects can be increased when indomethacin is combined with flunisolide.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with donepezil.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when Nepafenac is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with norfloxacin.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with imipramine.


The risk or severity of adverse effects can be increased when propofol is combined with meclizine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with methazolamide.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with mesoridazine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with maprotiline.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Metipranolol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with acetazolamide.


The risk or severity of adverse effects can be increased when nalbuphine is combined with rasagiline.


The risk or severity of adverse effects can be increased when clorazepate is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when barnidipine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with butalbital.


The risk or severity of adverse effects can be increased when Tolcapone is combined with efavirenz.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with tiagabine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Tramadol is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with nicardipine.


The risk or severity of adverse effects can be increased when alprazolam is combined with trimipramine.


The risk or severity of adverse effects can be increased when isoflurane is combined with maprotiline.


The risk or severity of adverse effects can be increased when pentazocine is combined with diazepam.


The risk or severity of adverse effects can be increased when budesonide is combined with fleroxacin.


The risk or severity of adverse effects can be increased when nitric oxide is combined with penbutolol.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with zonisamide.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with oxazepam.


The risk or severity of adverse effects can be increased when butenafine is combined with xylometazoline.


The risk or severity of adverse effects can be increased when butamben is combined with Milnacipran.


The risk or severity of adverse effects can be increased when perphenazine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with baclofen.


The risk or severity of adverse effects can be increased when amiodarone is combined with cilnidipine.


The risk or severity of adverse effects can be increased when bromazepam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when amiodarone is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when amiodarone is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Ramelteon is combined with desipramine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with carboplatin.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with dibucaine.


The risk or severity of adverse effects can be increased when floctafenine is combined with leflunomide.


The risk or severity of adverse effects can be increased when gabapentin is combined with chlormezanone.


The risk or severity of adverse effects can be increased when tretinoin is combined with papaverine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with domperidone.


The risk or severity of adverse effects can be increased when gabapentin is combined with phenobarbital.


The risk or severity of adverse effects can be increased when gabapentin is combined with Escitalopram.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with lidocaine.


The risk or severity of adverse effects can be increased when imipramine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Clobetasone.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when benazepril is combined with celecoxib.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Flibanserin.


The risk or severity of adverse effects can be increased when barnidipine is combined with enalapril.


The risk or severity of adverse effects can be increased when ketorolac is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when benztropine is combined with dicyclomine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Limaprost is combined with PENTAERYTHRITOL TETRANITRATE.


The risk or severity of adverse effects can be increased when venlafaxine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when diltiazem is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when diltiazem is combined with bumetanide.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Tolcapone.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with amitriptyline.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with pirenzepine.


The risk or severity of adverse effects can be increased when etodolac is combined with flunisolide.


The risk or severity of adverse effects can be increased when alprazolam is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with theobromine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when midazolam is combined with glutethimide.


The risk or severity of adverse effects can be increased when prazepam is combined with paroxetine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when ibuprofen is combined with alclofenac.


The risk or severity of adverse effects can be increased when PROCATEROL is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when meprobamate is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with zopiclone.


The risk or severity of adverse effects can be increased when loratadine is combined with tizanidine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with salicylamide.


The risk or severity of adverse effects can be increased when Fludarabine is combined with clozapine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with suprofen.


The risk or severity of adverse effects can be increased when fenoprofen is combined with loteprednol.


The risk or severity of adverse effects can be increased when indomethacin is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Etidocaine.


The risk or severity of adverse effects can be increased when benazepril is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when linezolid is combined with Asenapine.


The risk or severity of adverse effects can be increased when desipramine is combined with citalopram.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with clemastine.


The risk or severity of adverse effects can be increased when temazepam is combined with pimozide.


The risk or severity of adverse effects can be increased when irbesartan is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with mirtazapine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with meprobamate.


The risk or severity of adverse effects can be increased when Perospirone is combined with Retigabine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when clorazepate is combined with tizanidine.


The risk or severity of adverse effects can be increased when pentazocine is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when Prostaglandin E2 is combined with Carbetocin.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when gabapentin is combined with lovastatin.


The risk or severity of adverse effects can be increased when fexofenadine is combined with nefazodone.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Clobetasone.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when fexofenadine is combined with doxepin.


The risk or severity of adverse effects can be increased when gabapentin is combined with enflurane.


The risk or severity of adverse effects can be increased when brotizolam is combined with tetracaine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with felodipine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with ethotoin.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Naftifine.


The risk or severity of adverse effects can be increased when meperidine is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with irbesartan.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when sumatriptan is combined with promazine.


The risk or severity of adverse effects can be increased when Isoconazole is combined with isradipine.


The risk or severity of adverse effects can be increased when diazepam is combined with zopiclone.


The risk or severity of adverse effects can be increased when nabumetone is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when clorazepate is combined with cetirizine.


The risk or severity of adverse effects can be increased when clorazepate is combined with protriptyline.


The risk or severity of adverse effects can be increased when amifostine is combined with barnidipine.


The risk or severity of adverse effects can be increased when butalbital is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Mirabegron.


The risk or severity of adverse effects can be increased when docetaxel is combined with Radium-223 chloride.


The risk or severity of adverse effects can be increased when Carbetocin is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when tolmetin is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with thiopental.


The risk or severity of adverse effects can be increased when thioridazine is combined with etizolam.


The risk or severity of adverse effects can be increased when morphine is combined with trazodone.


The risk or severity of adverse effects can be increased when morphine is combined with pentazocine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with ethosuximide.


The risk or severity of adverse effects can be increased when butamben is combined with amitriptyline.


The risk or severity of adverse effects can be increased when butamben is combined with Tolcapone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Rotigotine.


The risk or severity of adverse effects can be increased when tetracaine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with butamben.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when cabergoline is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when decamethonium is combined with methacholine.


The risk or severity of adverse effects can be increased when Etomidate is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when pentazocine is combined with quetiapine.


The risk or severity of adverse effects can be increased when carprofen is combined with Propacetamol.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when meperidine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when cetirizine is combined with trimipramine.


The risk or severity of adverse effects can be increased when Calcifediol is combined with dihydrotachysterol.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with amikacin.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with loxapine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with ramipril.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when dobutamine is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with valsartan.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with rosiglitazone.


The risk or severity of adverse effects can be increased when prazosin is combined with indapamide.


The risk or severity of adverse effects can be increased when celecoxib is combined with resveratrol.


The risk or severity of adverse effects can be increased when captopril is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when Pramocaine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when clorazepate is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when clorazepate is combined with flunarizine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when selegiline is combined with furosemide.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with medrysone.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Normethadone.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Icatibant.


The risk or severity of adverse effects can be increased when Normethadone is combined with tiapride.


The risk or severity of adverse effects can be increased when amoxapine is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with clidinium.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with acetazolamide.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when quazepam is combined with dantrolene.


The risk or severity of adverse effects can be increased when isoproterenol is combined with Ephedrine.


The risk or severity of adverse effects can be increased when isoproterenol is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when isoproterenol is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when suprofen is combined with Tixocortol.


The risk or severity of adverse effects can be increased when budesonide is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Pentolinium.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Tixocortol.


The risk or severity of adverse effects can be increased when budesonide is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when ketorolac is combined with Mometasone.


The risk or severity of adverse effects can be increased when biperiden is combined with Tapentadol.


The risk or severity of adverse effects can be increased when benazepril is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when mepivacaine is combined with glutethimide.


The risk or severity of adverse effects can be increased when pirenzepine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when argatroban is combined with mesalamine.


The risk or severity of adverse effects can be increased when Bretylium is combined with quetiapine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with primidone.


The risk or severity of adverse effects can be increased when Clofarabine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Arotinolol is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when alprostadil is combined with Apixaban.


The risk or severity of adverse effects can be increased when Clofarabine is combined with tolazoline.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with procarbazine.


The risk or severity of adverse effects can be increased when reserpine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when floctafenine is combined with Tixocortol.


The risk or severity of adverse effects can be increased when pimozide is combined with Desloratadine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Normethadone.


The risk or severity of adverse effects can be increased when pimozide is combined with mepivacaine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with butalbital.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Pramocaine is combined with clemastine.


The risk or severity of adverse effects can be increased when morphine is combined with amisulpride.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Capsaicin.


The risk or severity of adverse effects can be increased when Propiverine is combined with HEROIN.


The risk or severity of adverse effects can be increased when nicergoline is combined with Sitaxsentan.


The risk or severity of adverse effects can be increased when atenolol is combined with acebutolol.


The risk or severity of adverse effects can be increased when quazepam is combined with trimipramine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when atenolol is combined with captopril.


The risk or severity of adverse effects can be increased when cocaine is combined with HEROIN.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with enoxacin.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with donepezil.


The risk or severity of adverse effects can be increased when bupropion is combined with citalopram.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when ondansetron is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Naftifine is combined with estrone.


The risk or severity of adverse effects can be increased when buprenorphine is combined with Drospirenone.


The risk or severity of adverse effects can be increased when methadone is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when Naftifine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Pramocaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Pramocaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Perospirone.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Pipamperone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with minoxidil.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with ritodrine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with droperidol.


The risk or severity of adverse effects can be increased when morphine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Panobinostat.


The risk or severity of adverse effects can be increased when oxprenolol is combined with meclizine.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with clemastine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with lidocaine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Pramocaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Atomoxetine.


The risk or severity of adverse effects can be increased when apomorphine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when biperiden is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when trazodone is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when scopolamine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when dexamethasone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when Isoflurophate is combined with Cevimeline.


The risk or severity of adverse effects can be increased when thalidomide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when dexamethasone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when imipramine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when nifedipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when felodipine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with ondansetron.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with tiagabine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with zonisamide.


The risk or severity of adverse effects can be increased when butorphanol is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when diclofenac is combined with Tixocortol.


The risk or severity of adverse effects can be increased when methadone is combined with brotizolam.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when methadone is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when butalbital is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when methysergide is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with Vilanterol.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when methysergide is combined with tetracycline.


The risk or severity of adverse effects can be increased when levorphanol is combined with Remoxipride.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with penbutolol.


The risk or severity of adverse effects can be increased when lorazepam is combined with topiramate.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when thalidomide is combined with triamterene.


The risk or severity of adverse effects can be increased when pimozide is combined with tetracaine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when levorphanol is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when labetalol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Arotinolol is combined with barnidipine.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Pipamperone is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with diflorasone.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when methylphenidate is combined with desipramine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with atenolol.


The risk or severity of adverse effects can be increased when haloperidol is combined with nitrazepam.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with oxymetholone.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with warfarin.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with pentosan polysulfate.


The risk or severity of adverse effects can be increased when METAXALONE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when aspirin is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when sulindac is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Lurasidone is combined with scopolamine.


The risk or severity of adverse effects can be increased when aspirin is combined with amcinonide.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with Telmisartan.


The risk or severity of adverse effects can be increased when ethotoin is combined with dantrolene.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Lurasidone.


The risk or severity of adverse effects can be increased when imipramine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when meprobamate is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Pipamperone is combined with enalapril.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Halobetasol.


The risk or severity of adverse effects can be increased when perphenazine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when olanzapine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when nitrendipine is combined with triamterene.


The risk or severity of adverse effects can be increased when perphenazine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with duloxetine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when diflunisal is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with fluoxetine.


The risk or severity of adverse effects can be increased when lorazepam is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when flunarizine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when lorazepam is combined with triazolam.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with clomipramine.


The risk or severity of adverse effects can be increased when tretinoin is combined with nisoldipine.


The risk or severity of adverse effects can be increased when lorazepam is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when alclometasone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with nortriptyline.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with amoxapine.


The risk or severity of adverse effects can be increased when nicardipine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when hydralazine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when tacrolimus is combined with rapamycin.


The risk or severity of adverse effects can be increased when Normethadone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when PROCATEROL is combined with nylidrin.


The risk or severity of adverse effects can be increased when Micafungin is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when pentazocine is combined with clomipramine.


The risk or severity of adverse effects can be increased when NALDEMEDINE is combined with Methylnaltrexone.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when flurazepam is combined with citalopram.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when etizolam is combined with ethotoin.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with thiothixene.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with azelastine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with actinomycin D.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Tixocortol.


The risk or severity of adverse effects can be increased when Butethal is combined with carisoprodol.


The risk or severity of adverse effects can be increased when rasagiline is combined with lithium ion.


The risk or severity of adverse effects can be increased when mepivacaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when mepivacaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when loteprednol is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when loteprednol is combined with galanthamine.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with quinidine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with haloperidol.


The risk or severity of adverse effects can be increased when dapsone is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Halobetasol is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when promethazine is combined with lithium ion.


The risk or severity of adverse effects can be increased when enalapril is combined with felodipine.


The risk or severity of adverse effects can be increased when citalopram is combined with bromocriptine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with droxidopa.


The risk or severity of adverse effects can be increased when naratriptan is combined with droperidol.


The risk or severity of adverse effects can be increased when midazolam is combined with gabapentin.


The risk or severity of adverse effects can be increased when duloxetine is combined with Asenapine.


The risk or severity of adverse effects can be increased when clonidine is combined with felodipine.


The risk or severity of adverse effects can be increased when butabarbital is combined with Pipamperone.


The risk or severity of adverse effects can be increased when methadone is combined with pimozide.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when Icatibant is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when sodium chloride is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when Halobetasol is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when Propacetamol is combined with estrone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with diazepam.


The risk or severity of adverse effects can be increased when methylergonovine is combined with methazolamide.


The risk or severity of adverse effects can be increased when fosinopril is combined with apraclonidine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with amprenavir.


The risk or severity of adverse effects can be increased when cabergoline is combined with Enasidenib.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with furosemide.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with tizanidine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with penbutolol.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when amifostine is combined with spironolactone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when codeine is combined with felbamate.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with thiothixene.


The risk or severity of adverse effects can be increased when nimesulide is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with Clevidipine.


The risk or severity of adverse effects can be increased when reserpine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with edrophonium.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Etidocaine.


The risk or severity of adverse effects can be increased when protriptyline is combined with citalopram.


The risk or severity of adverse effects can be increased when nortriptyline is combined with METAXALONE.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with estrone.


The risk or severity of adverse effects can be increased when propofol is combined with Melatonin.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when bepridil is combined with Clofarabine.


The risk or severity of adverse effects can be increased when bepridil is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when trazodone is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when rasagiline is combined with Clevidipine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when fenbufen is combined with medrysone.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Etomidate is combined with thiamylal.


The risk or severity of adverse effects can be increased when metoclopramide is combined with promazine.


The risk or severity of adverse effects can be increased when Etomidate is combined with halothane.


The risk or severity of adverse effects can be increased when dopamine is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when estrone is combined with Demecarium.


The risk or severity of adverse effects can be increased when thiothixene is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with lithium ion.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Escitalopram.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when nalbuphine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Articaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when secobarbital is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when proparacaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when proparacaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with GLYCEROL PHENYLBUTYRATE.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with clomipramine.


The risk or severity of adverse effects can be increased when ramipril is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when biperiden is combined with Normethadone.


The risk or severity of adverse effects can be increased when ramipril is combined with Torasemide.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with tretinoin.


The risk or severity of adverse effects can be increased when methscopolamine is combined with Tramadol.


The risk or severity of adverse effects can be increased when imipramine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with isoflurane.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Clevidipine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with duloxetine.


The risk or severity of adverse effects can be increased when enflurane is combined with Etidocaine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with fluoxetine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Octreotide.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with dyclonine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with propoxyphene.


The risk or severity of adverse effects can be increased when equilin is combined with edrophonium.


The risk or severity of adverse effects can be increased when Masoprocol is combined with epirizole.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when morphine is combined with Mersalyl.


The risk or severity of adverse effects can be increased when hydromorphone is combined with theobromine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with Bretylium.


The risk or severity of adverse effects can be increased when protriptyline is combined with procarbazine.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with ethotoin.


The risk or severity of adverse effects can be increased when Bortezomib is combined with minoxidil.


The risk or severity of adverse effects can be increased when prilocaine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when carprofen is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when docetaxel is combined with cabergoline.


The risk or severity of adverse effects can be increased when imipramine is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when equilin is combined with Demecarium.


The risk or severity of adverse effects can be increased when haloperidol is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when leflunomide is combined with flunisolide.


The risk or severity of adverse effects can be increased when docetaxel is combined with Cladribine.


The risk or severity of adverse effects can be increased when haloperidol is combined with dantrolene.


The risk or severity of adverse effects can be increased when Eletriptan is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when Nabilone is combined with D-mannitol.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with nifedipine.


The risk or severity of adverse effects can be increased when diltiazem is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when levorphanol is combined with Lurasidone.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with sotalol.


The risk or severity of adverse effects can be increased when risperidone is combined with thiamylal.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with penbutolol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Alvimopan.


The risk or severity of adverse effects can be increased when Vilazodone is combined with procarbazine.


The risk or severity of adverse effects can be increased when desoximetasone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with thiopental.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with papaverine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Nebivolol.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with nifedipine.


The risk or severity of adverse effects can be increased when butorphanol is combined with levorphanol.


The risk or severity of adverse effects can be increased when Paliperidone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with xylometazoline.


The risk or severity of adverse effects can be increased when butorphanol is combined with perphenazine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Mometasone is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with tiagabine.


The risk or severity of adverse effects can be increased when Mometasone is combined with memantine.


The risk or severity of adverse effects can be increased when morniflumate is combined with azelastine.


The risk or severity of adverse effects can be increased when mestranol is combined with Ospemifene.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with zonisamide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with hydralazine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when sulindac is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when ethanol is combined with CYSTEAMINE.


The risk or severity of adverse effects can be increased when Pramocaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Milnacipran is combined with droperidol.


The risk or severity of adverse effects can be increased when ramipril is combined with apraclonidine.


The risk or severity of adverse effects can be increased when ramipril is combined with methyldopa.


The risk or severity of adverse effects can be increased when hydromorphone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with enflurane.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when lidocaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when dibucaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Flibanserin is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when cilnidipine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when cocaine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when cocaine is combined with zotepine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when buspirone is combined with Halazepam.


The risk or severity of adverse effects can be increased when butabarbital is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when butabarbital is combined with flunarizine.


The risk or severity of adverse effects can be increased when argatroban is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when perphenazine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Pentolinium is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when pentamidine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when spironolactone is combined with fosinopril.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with clonidine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with isoproterenol.


The risk or severity of adverse effects can be increased when Bevantolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when meperidine is combined with thiothixene.


The risk or severity of adverse effects can be increased when ketorolac is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when meperidine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Pentolinium.


The risk or severity of adverse effects can be increased when Conivaptan is combined with cilazapril.


The risk or severity of adverse effects can be increased when meperidine is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when timolol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when timolol is combined with nicotine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with nisoldipine.


The risk or severity of adverse effects can be increased when doxazosin is combined with quetiapine.


The risk or severity of adverse effects can be increased when nefazodone is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when procyclidine is combined with Metixene.


The risk or severity of adverse effects can be increased when butorphanol is combined with meclizine.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with memantine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with niflumic acid.


The risk or severity of adverse effects can be increased when meclizine is combined with levodopa.


The risk or severity of adverse effects can be increased when amoxapine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when diflunisal is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when enflurane is combined with fexofenadine.


The risk or severity of adverse effects can be increased when halothane is combined with dipyridamole.


The risk or severity of adverse effects can be increased when perphenazine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when sulindac is combined with flunisolide.


The risk or severity of adverse effects can be increased when isoflurane is combined with Bretylium.


The risk or severity of adverse effects can be increased when triprolidine is combined with clonazepam.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when doxepin is combined with Salbutamol.


The risk or severity of adverse effects can be increased when acemetacin is combined with alclometasone.


The risk or severity of adverse effects can be increased when risperidone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Tramadol is combined with acetazolamide.


The risk or severity of adverse effects can be increased when Tramadol is combined with propofol.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with brotizolam.


The risk or severity of adverse effects can be increased when metoprolol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with haloperidol.


The risk or severity of adverse effects can be increased when irbesartan is combined with Olopatadine.


The risk or severity of adverse effects can be increased when floctafenine is combined with etodolac.


The risk or severity of adverse effects can be increased when floctafenine is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when floctafenine is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when etodolac is combined with Propacetamol.


The risk or severity of adverse effects can be increased when Voriconazole is combined with nimesulide.


The risk or severity of adverse effects can be increased when clozapine is combined with captopril.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with betamethasone.


The risk or severity of adverse effects can be increased when MELPERONE is combined with maprotiline.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with tetracaine.


The risk or severity of adverse effects can be increased when valsartan is combined with doxazosin.


The risk or severity of adverse effects can be increased when quetiapine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when bromazepam is combined with brotizolam.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with amisulpride.


The risk or severity of adverse effects can be increased when Olopatadine is combined with salicylamide.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with prednisone.


The risk or severity of adverse effects can be increased when Droxicam is combined with budesonide.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with terazosin.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when EDOXABAN is combined with Deferasirox.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when codeine is combined with halothane.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Naloxegol.


The risk or severity of adverse effects can be increased when Tapentadol is combined with PAMABROM.


The risk or severity of adverse effects can be increased when loxapine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when trimetrexate is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when selegiline is combined with prazosin.


The risk or severity of adverse effects can be increased when phenobarbital is combined with thiothixene.


The risk or severity of adverse effects can be increased when selegiline is combined with droperidol.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with citalopram.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with indapamide.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Riociguat.


The risk or severity of adverse effects can be increased when maprotiline is combined with periciazine.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when loxapine is combined with lidocaine.


The risk or severity of adverse effects can be increased when loxapine is combined with clemastine.


The risk or severity of adverse effects can be increased when nicotinamide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when tenoxicam is combined with acemetacin.


The risk or severity of adverse effects can be increased when etodolac is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when midazolam is combined with oxazepam.


The risk or severity of adverse effects can be increased when tizanidine is combined with papaverine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Articaine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with amcinonide.


The risk or severity of adverse effects can be increased when thiothixene is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when levodopa is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when midazolam is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when gabapentin is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when triflupromazine is combined with efavirenz.


The risk or severity of adverse effects can be increased when amphotericin b is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when sevoflurane is combined with furosemide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with tizanidine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when carisoprodol is combined with amoxapine.


The risk or severity of adverse effects can be increased when bepridil is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when Phenelzine is combined with droxidopa.


The risk or severity of adverse effects can be increased when loxapine is combined with isoflurane.


The risk or severity of adverse effects can be increased when Rufinamide is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when carisoprodol is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Rufinamide is combined with buprenorphine.


The risk or severity of adverse effects can be increased when loxapine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Nepafenac is combined with azelastine.


The risk or severity of adverse effects can be increased when azelastine is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when phenobarbital is combined with carisoprodol.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with sulpiride.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when thioridazine is combined with minoxidil.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with primidone.


The risk or severity of adverse effects can be increased when temazepam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Calcium citrate is combined with ergocalciferol.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Apremilast.


The risk or severity of adverse effects can be increased when betaxolol is combined with acebutolol.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with haloperidol.


The risk or severity of adverse effects can be increased when betaxolol is combined with captopril.


The risk or severity of adverse effects can be increased when nabumetone is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when brimonidine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when clozapine is combined with furosemide.


The risk or severity of adverse effects can be increased when mecamylamine is combined with pentazocine.


The risk or severity of adverse effects can be increased when etodolac is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when lithium ion is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Telaprevir is combined with propafenone.


The risk or severity of adverse effects can be increased when methadone is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with sotalol.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when terbutaline is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Aliskiren.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when clorazepate is combined with propofol.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when nystatin is combined with isradipine.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when carisoprodol is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when triazolam is combined with tizanidine.


The risk or severity of adverse effects can be increased when diazepam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with clonidine.


The risk or severity of adverse effects can be increased when meperidine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when ramipril is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when Salsalate is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when diazepam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Tapentadol is combined with theobromine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Salsalate is combined with Mometasone.


The risk or severity of adverse effects can be increased when Nepafenac is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with ibuprofen.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with protriptyline.


The risk or severity of adverse effects can be increased when benazepril is combined with lisinopril.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with cetirizine.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with selegiline.


The risk or severity of adverse effects can be increased when ketorolac is combined with DESONIDE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with citalopram.


The risk or severity of adverse effects can be increased when captopril is combined with diclofenac.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when oxprenolol is combined with butalbital.


The risk or severity of adverse effects can be increased when nifedipine is combined with hydralazine.


The risk or severity of adverse effects can be increased when triazolam is combined with cetirizine.


The risk or severity of adverse effects can be increased when amisulpride is combined with etizolam.


The risk or severity of adverse effects can be increased when triazolam is combined with protriptyline.


The risk or severity of adverse effects can be increased when methyldopa is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when oxaprozin is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when Carbetocin is combined with timolol.


The risk or severity of adverse effects can be increased when cetirizine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with benzocaine.


The risk or severity of adverse effects can be increased when reserpine is combined with butorphanol.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when amiodarone is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when oxycodone is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when dextroamphetamine is combined with procarbazine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with furosemide.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with tizanidine.


The risk or severity of adverse effects can be increased when buspirone is combined with trimipramine.


The risk or severity of adverse effects can be increased when thioridazine is combined with fosinopril.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when amobarbital is combined with baclofen.


The risk or severity of adverse effects can be increased when triamcinolone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with nicardipine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when halothane is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when indomethacin is combined with aspirin.


The risk or severity of adverse effects can be increased when halothane is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when amobarbital is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with methazolamide.


The risk or severity of adverse effects can be increased when lidocaine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when triamcinolone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Flibanserin.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when ketamine is combined with felbamate.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Etomidate.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with antipyrine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when estazolam is combined with clonidine.


The risk or severity of adverse effects can be increased when etodolac is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when sulconazole is combined with nilvadipine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with trimipramine.


The risk or severity of adverse effects can be increased when etodolac is combined with flumethasone.


The risk or severity of adverse effects can be increased when CALCIUM GLUCONATE is combined with Calcifediol.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with methacholine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Nilotinib.


The risk or severity of adverse effects can be increased when meperidine is combined with scopolamine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when isradipine is combined with atenolol.


The risk or severity of adverse effects can be increased when amobarbital is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when cisapride is combined with sulpiride.


The risk or severity of adverse effects can be increased when ramipril is combined with captopril.


The risk or severity of adverse effects can be increased when olanzapine is combined with risperidone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with gabapentin.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with clomipramine.


The risk or severity of adverse effects can be increased when ipratropium is combined with oxybutynin.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Phenelzine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Crizotinib.


The risk or severity of adverse effects can be increased when isoproterenol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Atomoxetine is combined with oxycodone.


The risk or severity of adverse effects can be increased when leflunomide is combined with Deferasirox.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Lapatinib.


The risk or severity of adverse effects can be increased when antipyrine is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with risperidone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with meclizine.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when carisoprodol is combined with efavirenz.


The risk or severity of adverse effects can be increased when acebutolol is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with lithium ion.


The risk or severity of adverse effects can be increased when diazepam is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when methylene blue is combined with clenbuterol.


The risk or severity of adverse effects can be increased when methylene blue is combined with Bambuterol.


The risk or severity of adverse effects can be increased when enalapril is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with pargyline.


The risk or severity of adverse effects can be increased when perphenazine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when nabumetone is combined with salicylamide.


The risk or severity of adverse effects can be increased when Carbetocin is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Carbetocin is combined with felodipine.


The risk or severity of adverse effects can be increased when barnidipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when butamben is combined with triprolidine.


The risk or severity of adverse effects can be increased when trazodone is combined with tiagabine.


The risk or severity of adverse effects can be increased when Ifenprodil is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when thiopental is combined with propoxyphene.


The risk or severity of adverse effects can be increased when thiopental is combined with dyclonine.


The risk or severity of adverse effects can be increased when dibucaine is combined with Articaine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Olopatadine is combined with diflunisal.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when thioridazine is combined with triazolam.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when Tasimelteon is combined with sertraline.


The risk or severity of adverse effects can be increased when rizatriptan is combined with nefazodone.


The risk or severity of adverse effects can be increased when meperidine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when enalapril is combined with Olopatadine.


The risk or severity of adverse effects can be increased when xylometazoline is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when Rotigotine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when furosemide is combined with netilmicin.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when carbamazepine is combined with dibucaine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with nalbuphine.


The risk or severity of adverse effects can be increased when clozapine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with bepridil.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when furazolidone is combined with isoproterenol.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with triamterene.


The risk or severity of adverse effects can be increased when meprobamate is combined with mesoridazine.


The risk or severity of adverse effects can be increased when meprobamate is combined with maprotiline.


The risk or severity of adverse effects can be increased when Propiverine is combined with buprenorphine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with naratriptan.


The risk or severity of adverse effects can be increased when tetracaine is combined with felbamate.


The risk or severity of adverse effects can be increased when ethopropazine is combined with buprenorphine.


The risk or severity of adverse effects can be increased when spiramycin is combined with simvastatin.


The risk or severity of adverse effects can be increased when bupropion is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Flibanserin is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with anastrozole.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when desipramine is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with triazolam.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when cocaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when Rotigotine is combined with captopril.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when butamben is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with acebutolol.


The risk or severity of adverse effects can be increased when butamben is combined with clemastine.


The risk or severity of adverse effects can be increased when Halazepam is combined with felbamate.


The risk or severity of adverse effects can be increased when MEPHENTERMINE is combined with procarbazine.


The risk or severity of adverse effects can be increased when aspirin is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when trandolapril is combined with benazepril.


The risk or severity of adverse effects can be increased when sulpiride is combined with thiopental.


The risk or severity of adverse effects can be increased when aspirin is combined with fenbufen.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with Eprosartan.


The risk or severity of adverse effects can be increased when loxapine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with clonazepam.


The risk or severity of adverse effects can be increased when Toloxatone is combined with Bambuterol.


The risk or severity of adverse effects can be increased when labetalol is combined with furosemide.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with clomipramine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with phenytoin.


The risk or severity of adverse effects can be increased when Toloxatone is combined with clenbuterol.


The risk or severity of adverse effects can be increased when carprofen is combined with equilin.


The risk or severity of adverse effects can be increased when brotizolam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when ketamine is combined with etizolam.


The risk or severity of adverse effects can be increased when Aluminium is combined with misoprostol.


The risk or severity of adverse effects can be increased when meprobamate is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when LISURIDE is combined with simvastatin.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Lurasidone.


The risk or severity of adverse effects can be increased when LISURIDE is combined with propoxyphene.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Nebivolol.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with nifedipine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with papaverine.


The risk or severity of adverse effects can be increased when thalidomide is combined with Eprosartan.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when nicergoline is combined with clofazimine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Salsalate.


The risk or severity of adverse effects can be increased when fenoprofen is combined with paramethasone.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with zonisamide.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with ondansetron.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with tiagabine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with salicylamide.


The risk or severity of adverse effects can be increased when salicylic acid is combined with acemetacin.


The risk or severity of adverse effects can be increased when Carbetocin is combined with propofol.


The risk or severity of adverse effects can be increased when atenolol is combined with furosemide.


The risk or severity of adverse effects can be increased when atenolol is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Tramadol is combined with thiopental.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with flumethasone.


The risk or severity of adverse effects can be increased when metoclopramide is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when Tramadol is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when clozapine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when D-mannitol is combined with nifedipine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Trabectedin.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when lorazepam is combined with secobarbital.


The risk or severity of adverse effects can be increased when chlorambucil is combined with clozapine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Olsalazine is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when methazolamide is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with milrinone.


The risk or severity of adverse effects can be increased when epirizole is combined with medrysone.


The risk or severity of adverse effects can be increased when Lurasidone is combined with mesoridazine.


The risk or severity of adverse effects can be increased when mesalamine is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when cabergoline is combined with Quinine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with timolol.


The risk or severity of adverse effects can be increased when RIFAPENTINE is combined with clopidogrel.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Quinupristin.


The risk or severity of adverse effects can be increased when Articaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when imipramine is combined with methazolamide.


The risk or severity of adverse effects can be increased when pentoxifylline is combined with diflunisal.


The risk or severity of adverse effects can be increased when imipramine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with brotizolam.


The risk or severity of adverse effects can be increased when amobarbital is combined with fexofenadine.


The risk or severity of adverse effects can be increased when spironolactone is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when oxycodone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when aspirin is combined with diflunisal.


The risk or severity of adverse effects can be increased when thioridazine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when aspirin is combined with dorzolamide.


The risk or severity of adverse effects can be increased when triamterene is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when sevoflurane is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when carprofen is combined with Tixocortol.


The risk or severity of adverse effects can be increased when Naftifine is combined with Propacetamol.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with meperidine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when tiagabine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with ropinirole.


The risk or severity of adverse effects can be increased when furosemide is combined with gentamicin.


The risk or severity of adverse effects can be increased when terazosin is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when furosemide is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Clobetasone.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with metoprolol.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with bepridil.